Tag: oncogene

US NCI Sponsors Senhwa Biosciences’ Second Program-IND Submitted for Clinical Trial Targeting MYC-Aberrant Lymphoma

TAIPEI and SAN DIEGO, Aug. 7, 2025 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a new drug development company focusing on first-in-class therapeutics for...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Name

This field is for validation purposes and should be left unchanged.

HomeTagsOncogene

Etoiles Capital Group Co., Ltd Announces Pricing of US$5.6 million Initial Public Offering

Orezone to Commence Trading on the ASX Under Ticker “ORE”

Bluejay Diagnostics Provides Second Quarter Business and Corporate Update

Tag: oncogene

US NCI Sponsors Senhwa Biosciences’ Second Program-IND Submitted for Clinical Trial Targeting MYC-Aberrant Lymphoma

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us